Related Experiment Video
Updated: Feb 20, 2026

Characterization of Adipocyte-Derived Extracellular Vesicle Secretion Using a CD63-GFP Reporter Mouse Model In Vivo and In Vitro
Published on: December 5, 2025
Adiponectin: mechanistic insights and clinical implications
1Department of Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-8521, USA. Aslan.Turer@UTSouthwestern.edu
Adiponectin, an adipocyte-secreted protein, plays a crucial role in metabolic health. This review highlights its functions, mechanisms, and established role as a biomarker for insulin sensitivity and cardiovascular disease.
Area of Science:
- Biochemistry
- Endocrinology
- Metabolic Research
Background:
- Adiponectin is an adipocyte-derived secretory protein extensively studied for its diverse functions.
- It originates in adipose tissue and is associated with generally positive metabolic effects.
- Adiponectin is recognized as a significant biomarker in clinical research.
Purpose of the Study:
- To review the key characteristics of adiponectin.
- To highlight recent findings on its mechanism of action.
- To summarize epidemiological data supporting its role as a biomarker.
Main Methods:
- In vitro studies using tissue culture systems.
- In vivo studies involving genetic manipulation of rodent models.
- Analysis of epidemiological data from clinical studies.
Main Results:
- Adiponectin exhibits a wide range of functions.
- Recent research provides insights into its mechanism of action.
- Epidemiological data confirms adiponectin as a biomarker for insulin sensitivity and cardiovascular disease.
Conclusions:
- Adiponectin is a complex molecule with significant metabolic implications.
- Its role as a biomarker for various diseases is well-established.
- Further research continues to elucidate its multifaceted actions.
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Insulin: The Receptor and Signaling Pathways

